Invion and Hovione Partner to Develop Inhaled Zafirlukast for Asthma – Lung Disease News


Lung Disease News

Invion and Hovione Partner to Develop Inhaled Zafirlukast for Asthma
Lung Disease News
Australia-based pharmaceutical company Invion Ltd. recently signed a partnership agreement with Hovione Scientia Ltd., a multinational pharmaceutical company focused on developing inhaled therapeutics, for the advancement of INV104 (zafirlukast) as a …

and more »

View full post on asthma – Google News

Invion and Hovione Partner to Develop Inhaled Zafirlukast for Asthma Lung … – Lung Disease News

Invion and Hovione Partner to Develop Inhaled Zafirlukast for Asthma Lung
Lung Disease News
GSK Expands Its COPD And Asthma Portfolio Across The US. Australia-based pharmaceutical company Invion Ltd. recently signed a partnership agreement with Hovione Scientia Ltd., a multinational pharmaceutical company focused on developing inhaled …

View full post on asthma – Google News

Dr. Reddy’s Laboratories launches Zafirlukast tablets in US – Trading Markets (press release)

Dr. Reddy's Laboratories launches Zafirlukast tablets in US
Trading Markets (press release)
Laboratories (NYSE: RDY | PowerRating) reported on Saturday the launch of its Zafirlukast tablets (10mg and 20mg) in the US market, for treating asthma.
Dr Reddy's gets USFDA nodIndian Express
Dr. Reddy's launches generic AccolateDrug Store News
Dr Reddy's gets FDA nod to launch Zafirlukast in USSify
Indlaw.com
all 57 news articles »

View full post on asthma – Google News

Dr Reddy’s introduces Zafirlukast tablets in US – Pharmaceutical Business Review

Dr Reddy's introduces Zafirlukast tablets in US
Pharmaceutical Business Review
Accolate, an oral prescription medicine used to treat asthma, works by blocking substances in the body called leukotrienes, which may contribute to the
Dr Reddy's gets nod to launch ZafirlukastSify
Dr. Reddy's launches generic asthma drug in USMarketWatch
Dr Reddy's gets FDA nod to launch anti-asthma tablets in USEconomic Times
India Infoline.com
all 49 news articles »

View full post on asthma – Google News

Dr Reddy’s gets nod to launch Zafirlukast – Sify

Dr Reddy's gets nod to launch Zafirlukast
Sify
Zafirlukast is a prescription medicine used for treating asthma. According to IMS Health, the medicine had total US sales of approximately $50 million for
Dr. Reddy's launches generic asthma drug in USMarketWatch
Dr Reddy's gets FDA nod to launch anti-asthma tablets in USEconomic Times
Dr Reddys Laboratories announces the launch of Zafirlukast tabletsIndia Infoline.com

all 41 news articles »

View full post on asthma – Google News